Key Segments:
By Product
-
Blood Glucose Monitoring
-
Infectious Disease Monitoring
-
Cardiometabolic Disease Testing
-
Hematology Testing
-
Others
By Sample
-
Blood
-
Nasal and Oropharyngeal Swabs
-
Urine
-
Others
By End- User
-
Hospital Bedside
-
Physican’s Office Lab
-
Urgent Care & Retail Clinics
-
Home & Self Testing
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
Egypt
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: Growth is driven by rising global chronic and infectious disease burden, technological innovations in biosensors and microfluidics, AI integration enhancing diagnostic precision, expanding home care testing adoption, and increasing demand for rapid near-patient diagnostic results across all care settings.
Ans: North America dominated with approximately 43% revenue share in 2025, while Asia-Pacific is expected to register the fastest CAGR of 8.97% through 2035.
Ans: Blood Glucose Monitoring dominated with approximately 54% revenue share in 2025, while Molecular Diagnostics is the fastest-growing product segment through 2035.
Ans: The Market was valued at USD 54.50 Billion in 2025 and is projected to reach USD 114.65 Billion by 2035.
Ans: The Point-of-Care Diagnostics Market is expected to grow at a CAGR of 7.72% during 2026–2035.